As an investor I am very disappointed to hear about the decision regarding the halt of the right to try utilization of Leronlimab. We all believe that this is a life saving drug and part of what keeps this community going are the "anecdotes" of a loved one's life being saved by this drug.
I would encourage the company to reassess it's decision and figure out away to make Leronlimab available when there is no other hope.